Gene · 4830
Papers3,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blood-Brain Barrier Disintegration in Growth-Restricted Fetuses with Brain Sparing Effect. | Int J Mol Sci | 2022 | 36293204 | PubTator, text mining | PubMed |
| Tsw - A case study on structure-function puzzles in plant NLRs with unusually large LRR domains. | Front Plant Sci | 2022 | 36275604 | PubTator, text mining | PubMed |
| Cleavage of AUF1 by Coxsackievirus B Affects DDX5 Regulatory on Viral Replication through iTRAQ Proteomics Analysis. | Biomed Res Int | 2022 | 36246972 | PubTator, text mining | PubMed |
| In Vitro Transfection of Up-Regulated Genes Identified in Favorable-Outcome Neuroblastoma into Cell Lines. | Cells | 2022 | 36231133 | PubTator, text mining | PubMed |
| Nonamer dependent RAG cleavage at CpGs can explain mechanism of chromosomal translocations associated to lymphoid cancers. | PLoS Genet | 2022 | 36228010 | PubTator, text mining | PubMed |
| SET/PP2A signaling regulates macrophage positioning in hypoxic tumor regions by amplifying chemotactic responses. | Exp Mol Med | 2022 | 36224346 | PubTator, text mining | PubMed |
| Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning. | Nat Commun | 2022 | 36216831 | PubTator, text mining | PubMed |
| Aberrant expression of SPAG6 and NM23 predicts poor prognosis of human osteosarcoma. | Front Genet | 2022 | 36199573 | PubTator, text mining | PubMed |
| Prognostic and clinicopathological significance of nm23-H1 expression in non-small cell lung cancer: A meta-analysis. | Medicine (Baltimore) | 2022 | 36181032 | PubTator, text mining | PubMed |
| MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | Genome Biol | 2022 | 36180891 | PubTator, text mining | PubMed |
| Metabolic remodeling of pyrimidine synthesis pathway and serine synthesis pathway in human glioblastoma. | Sci Rep | 2022 | 36175487 | PubTator, text mining | PubMed |
| KAI1/CD82 gene and autotaxin-lysophosphatidic acid axis in gastrointestinal cancers. | World J Gastrointest Oncol | 2022 | 36160748 | PubTator, text mining | PubMed |
| Plasmid DNA for Therapeutic Applications in Cancer. | Pharmaceutics | 2022 | 36145609 | PubTator, text mining | PubMed |
| Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer's Disease and the Subtype Classification. | Int J Mol Sci | 2022 | 36142676 | PubTator, text mining | PubMed |
| Identification of the Regulatory Targets of miR-3687 and miR-4417 in Prostate Cancer Cells Using a Proteomics Approach. | Int J Mol Sci | 2022 | 36142477 | PubTator, text mining | PubMed |
| From HDAC to Voltage-Gated Ion Channels: What's Next? The Long Road of Antiepileptic Drugs Repositioning in Cancer. | Cancers (Basel) | 2022 | 36139561 | PubTator, text mining | PubMed |
| Human cone elongation responses can be explained by photoactivated cone opsin and membrane swelling and osmotic response to phosphate produced by RGS9-catalyzed GTPase. | Proc Natl Acad Sci U S A | 2022 | 36122241 | PubTator, text mining | PubMed |
| Integrated bioinformatical analysis, machine learning and in vitro experiment-identified m6A subtype, and predictive drug target signatures for diagnosing renal fibrosis. | Front Pharmacol | 2022 | 36120336 | PubTator, text mining | PubMed |
| Extracellular vesicle expansion of PMIS-miR-210 expression inhibits colorectal tumour growth via apoptosis and an XIST/NME1 regulatory mechanism. | Clin Transl Med | 2022 | 36116139 | PubTator, text mining | PubMed |
| Surface tension of model tissues during malignant transformation and epithelial-mesenchymal transition. | Front Cell Dev Biol | 2022 | 36111347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4830/papers?page=16